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A consensus has not yet been reached regarding the accuracy of people with schizophrenia in self-reporting their real-life
functioning. In a large (n= 618) cohort of stable, community-dwelling schizophrenia patients we sought to: (1) examine the
concordance of patients’ reports of their real-life functioning with the reports of their key caregiver; (2) identify which patient
characteristics are associated to the differences between patients and informants. Patient-caregiver concordance of the ratings in
three Specific Level of Functioning Scale (SLOF) domains (interpersonal relationships, everyday life skills, work skills) was evaluated
with matched-pair t tests, the Lin’s concordance correlation, Somers’ D, and Bland–Altman plots with limits of agreement (LOA).
Predictors of the patient-caregiver differences in SLOF ratings were assessed with a linear regression with multivariable fractional
polynomials. Patients’ self-evaluation of functioning was higher than caregivers’ in all the evaluated domains of the SLOF and 17.6%
of the patients exceeded the LOA, thus providing a self-evaluation discordant from their key caregivers. The strongest predictors of
patient-caregiver discrepancies were caregivers’ ratings in each SLOF domain. In clinically stable outpatients with a moderate
degree of functional impairment, self-evaluation with the SLOF scale can become a useful, informative and reliable clinical tool to
design a tailored rehabilitation program.
npj Schizophrenia            (2021) 7:11 ; https://doi.org/10.1038/s41537-021-00140-9
INTRODUCTION
Patients with schizophrenia show notable impairments in every-
day functioning, including deficits in social, vocational, and
residential domains, even during periods of remission from active
psychosis1. Many different instruments are available for the
assessment of real-life functioning, including rating scales that
employ informant and self-reports2, direct observations by trained
clinicians3, and performance-based measures4.
Studies have indicated that informant reports regarding the
specific behaviors reflective of community functioning may be the
most reliable assessment of functioning5. However, many people
with schizophrenia do not have informants readily available to
report on their functioning6 or they may have limited contact with
them7. Also, in outpatient samples, there are many behaviors to
which the clinician has no access and the use of self-reports may
be important to get a clearer picture of the subjective level of
functioning of patients. Nonetheless, self-reports of everyday
functioning on the part of people with schizophrenia have been
found to be poorly correlated with the reports of other informants
and with their own performance of tests of cognition and
functional abilities8.
Different studies have investigated the accuracy of self-
appraisal in both clinical populations and healthy individuals.
Healthy individuals tend to overestimate their abilities. In
particular, poor performers showed a particularly positive bias,
i.e., a tendency to overestimate their performance9,10. On the
contrary, people with mild depressive symptoms tend to be more
accurate in their self-evaluation11, with more severe depression
symptoms associated with underestimation of functioning7. In
studies of people with neurological conditions including multiple
sclerosis12, traumatic brain injury13, mild cognitive impairment,
and very mild Alzheimer disease14 similar results have been found:
patients with poorer neuropsychological test performance tend to
underestimate their impairment.
Similarly, people with schizophrenia have substantial problems
in self-reporting everyday functioning7, as only one-third of
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chronic schizophrenia patients may be able to accurately report
their functional abilities5. This is not surprising, as lack of insight is
a prevalent feature of schizophrenia and is found across
cultures15,16, in early and late17,18, acute and non-acute19 phases
of the disorder. Poor insight in schizophrenia includes unaware-
ness of symptoms, treatment need, psychosocial consequences of
illness20, and alterations in cognitive processes, which involve the
capacity for self-reflectiveness and resistance to excessive
certainty21,22. This deficit is not just the consequence of a failure
to notice a problem or accept a label but a failure to make
consensually valid sense of complex and potentially traumatic
experience, which limits patients’ abilities to form integrated sense
of self23. This lack of insight likely has multiple roots, which include
symptom severity, deficits in neurocognition, social cognition and
metacognition, and sociopolitical factors23, and influences
patients’ self-appraisal of their performance on objective tests24,25
and of their own levels of real-life functioning6,7,26. In particular,
people with schizophrenia tend, on average, to underestimate the
severity of their symptoms and to overestimate their psychosocial
functioning5.
Moreover, analyses of variables influencing misestimation of
self-reported real-life functioning showed that a higher level of
positive symptoms and poorer cognitive and functional capacity
associated with a tendency to overestimate real-life functioning5.
Conversely, depression showed a unique relationship with real-life
functioning, as it showed both adverse impacts on functioning
and positive correlations with self-assessment abilities. Indeed,
more severe depressive symptoms were associated with less
overestimation in self-reports5 and with a higher degree of
underestimation7. Besides depression, this pattern of personal
appraisal is also potentially linked to insight and stigma. About
this complex interplay, several studies found that self-stigma
mediated the relationship between insight and depression27–29.
Others showed that, beyond stigma, a generally negative appraisal
of one’s future influences the effects of insight on mood30.
The purpose of this study was to examine the concordance of
schizophrenia patients’ reports of their everyday life functional
status with the reports of their informant and to identify which
patient characteristics were associated with disagreement in these
ratings between patients and caregivers.
We hypothesized that, based on previous studies, self-reported
real-word functioning by people with schizophrenia would be
poorly convergent with informants’ reports and that higher levels
of cognitive performance and real-life functioning, rated by
caregivers, would predict more concordant functioning ratings
between patients and informants.
RESULTS
Study population characteristics
The study population included 618 patients followed up in the 24
centers that participated in the second wave of the Italian
Network for Research on Psychoses (NIRP) study between March
2016 and January 2018. Patients were all diagnosed with
schizophrenia according to DSM-IV, mostly males (69.1%), aged
on average 45.1±10.5 years and received 11.7±3.4 years of
education. Only a minority of them lived in residential facilities
(10.1%), and 34.4% were working. Antipsychotic treatment, mainly
second-generation antipsychotics (69.3%), was administered to
the vast majority of patients (97.4%); 54.4% were subject to
polypharmacy, 34.3% to psychosocial intervention, 14.9% to
psychotherapy, and 43.7% reported a relapse during the past 4
years. Psychiatric follow-up visits were scheduled monthly on
about half of the patients (48.5%), whereas 17.4% of them needed
a tighter control (Table 1). Illness-related factors, functional
capacity, and real-life functioning mean scores are reported in
detail in a previous paper31.
Comparison between patient and caregiver evaluation of real-
life functioning
Patients’ self-evaluation of functioning was higher than caregivers’
in all the evaluated items of the SLOF scale. Their mean scores
were significantly different (Table 2) for all the items of the
interpersonal relationship and work skills domains, and for most
items of the everyday life skills. However, even if statistical
significance was achieved, the mean difference between the
paired scores was usually quite small in magnitude. Percent
agreement and Gwet’s agreement’s coefficient were always high
or very high: the smallest Gwet’s AC was 0.782 for the “Participates
in groups” item of the interpersonal relationships domain, and it
ranged 0.782–0.827 in interpersonal relationships, 0.813–0.958 in
everyday life skills, and 0.793–0.866 in work skills. All probabilistic
benchmark intervals were 0.600–0.800 or 0.800–1.000, thus
indicating an at least substantial agreement between patient
and caregiver. Also, when evaluating concordance on the three
domains’ scores evaluated, we found that patients overestimated
their functioning with respect to caregivers in all domains (Table 3
and 4). All paired differences were significant; however, the largest
ones were barely over 1 point. Lin’s concordance ranged
0.766–0.874 and Somers’ D was between 0.25 and 0.27 (indicating
a 25–27% probability that functioning scores self-assessed by
patients exceeded those assessed by caregivers).
The Bland–Altman plots (Fig. 1) confirmed the high concor-
dance of patient and caregiver assessments, as most subjects were
placed within the limits of agreement (LOA), for all three domains.
Those who lied outside the LOA were distributed quite randomly,
only slightly more prevalent in the upper part of the graph
(patients’ scores higher than caregivers’ scores) and in the central
part of the mean total range (average values of functioning).
These patients overall account for 17.6% of the study population
Table 1. Socio-demographic and clinical variables of the study
population.
Gender (% males) 69.1
Age (years, mean ± SD) 45.1 ± 10.5
Education (years, mean ± SD) 11.7 ± 3.4
Working (%) 34.4
Currently in a residential facility (%) 10.1





Both first- and second-generation (%) 15.0
Antidepressants (%) 17.6




Any psychosocial interventions (%) 34.3
Psychotherapy (%) 14.9
Home care (%) 8.3
Relapse during past 4 years (%) 43.7
Frequency of follow-up visits (%)
Monthly 48.5
Less than monthly 34.1
More than monthly 17.4
SD standard deviation
P. Rocca et al.
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(n= 83); 13.4% exceeded LOA in only one SLOF domain, 2.1%
exceeded LOAs in two SLOF domains, and 2.1% in all the three
SLOF domains.
Predictors of patient-caregiver discrepancies in the evaluation
of real-life functioning
From the regression analyses performed using multiple imputa-
tion and multivariable fractional polynomials (MFPs, Table 4 and
Fig. 2), we found that caregiver scores in each of the three
domains of the SLOF analyzed were the strongest predictors of
patient-caregiver discrepancies with negative coefficients. This
indicates that patients’ overestimation was related to low
caregiver’s scores; patient’s estimation was less discrepant when
caregiver scores were higher and for the Interpersonal Relation-
ships and Work Skills domains at higher caregiver scores
corresponded underestimation of patients. Avolition was asso-
ciated with the patient-caregiver discrepancy in the evaluation of
interpersonal relationships and, to a lesser extent, of work skills:
more severe avolition was associated with more precise patient’s
self-evaluations. Expressive deficits were associated with patient-
caregiver discrepancy in work skills, positive symptoms with
patient-caregiver discrepancy in interpersonal relationships, and
disorganization symptoms with patient-caregiver discrepancy in
everyday life skills domain with a similar negative relation, i.e.,
more severe symptoms were associated with patient’s self-
evaluations closer to caregivers’ ones. Finally, higher speed of
processing in the MCCB was poorly associated with a higher level
of patient’s overestimation in the work skills domain.
DISCUSSION
This study aimed at two main goals: (a) to assess the concordance
between real-world functioning self-reported by people with
schizophrenia and reports generated by informants; (b) to
evaluate predictors of the agreement between these two
evaluations.
To our knowledge, this is the largest study carried out so far
examining awareness of functional deficits in people with
schizophrenia. Subjects participating in this study were living in
the community and stabilized on antipsychotic treatment and
were evaluated for their everyday life skills, interpersonal abilities,
and work skills.
Concerning the first aim, our results demonstrated good
concordance between self-reported functioning and informant
reports, contrary to our research hypothesis. About 5/6 of patients
self-evaluated their real-life functioning in concordance with their
caregivers’ estimation, whereas only 17.6% of patients were poorly
concordant, mostly on one single domain of functioning. These
data suggest that patients had few problems in reporting their
real-life functioning and that self-report could be informative and
should be considered to design rehabilitation projects.
This finding is in contrast with previous studies showing that
more than half of patients were inaccurate raters of their
abilities5,7,8,32. These contrasting results may be owing to
differences in the samples and in the types of informants. First,
our patients were community-dwelling clinically stable patients,
with a good service engagement and a moderate degree of
functional impairment31. Moreover, about 2/3 of them underwent
scheduled follow-up visits at least once every month for 4 years,
which suggests a stable course of the illness and confirms a high
service engagement that might have contributed to our patients’
good awareness about their own real-life functioning and to the
high concordance with informants’ ratings. In other terms, as
shown by a recent study presented by Vohs et al.33, we can
assume that this meaningful engagement with mental health
services could improve patients’ ability to appraise the con-
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enhanced level of cognitive and clinical insight could have led a
considerable portion of the patients in our sample to recovery,
intended as a meaningful interpretation of the challenges the
disorder poses and a possibility to meaningfully live with
schizophrenia34. As regards the informant, in our study and in
the Italian context it was mostly a key caregiver, the individual
most frequently and closely in contact with the patient, which
shares many time and activities with patients. This may have led to
a greater concordance of their viewpoints about patients’ real-life
functioning, not in line with previous studies that chose the high
contact clinical as informant5,7,8,32. We hypothesize that this type
of social context influences both the patient, who is constantly
made aware of her/his functional limits by the caregiver and the
caregiver, who is able to accurately evaluate the patient’s
functioning in the wake of her/his continuous relationship with
the patient. Moreover, as they share similar roles in patients’ lives
and therefore similar point of view, the choice of key caregivers as
informants entails a high level of homogeneity among different
caregivers’ evaluations. Accordingly, unlike other studies where
informants’ evaluations where performed by non-clinicians who
have different roles in the patients’ lives (e.g., key caregivers, close
relatives, and friends simultaneously in the same sample), we did
not expect a high degree of variability depending on the
informants’ role in the patients’ lives.
About the second aim, different types of errors may occur when
asking people with schizophrenia to self-rate their functional skills,
including misunderstanding the items on a rating scale, inaccu-
rately conceptualizing normal functioning, and making inaccurate
comparisons to external standards. These types of errors could
derive from cognitive deficits, from the severity of specific
symptomatic dimensions, and from the socio-demographic
characteristics of the patients. Identifying which variables were
associated with self-rated real-life functioning misestimation can
be useful to determine which patients are more likely to give a
biased self-evaluation.
The strongest predictors of patient-caregiver discrepancies in all
the three SLOF domains were caregivers’ scores. This is an
expected result, because the magnitude of patient-caregiver
disagreement is at least partly constrained by the reference value
represented by the caregiver score; as such, in our regression
models, the caregiver score was essential to adjust the predictors’
coefficient estimates. Patients who received higher ratings from
caregivers showed better concordance with the caregiver’s
evaluation. This finding is consistent with our research hypothesis
and with previous studies showing that patients who have poorer
functioning assessed by the informant tend to overestimate their
own functioning5,7,8. However, in our study inaccuracy, measured
by Bland–Altman LOA, affected only 1/6 of the patients, which is a
much smaller proportion compared with previous studies.
As to symptoms, at odds with previous studies5,7, we did not
find any association between self-rating of real-world functioning
and depressive symptoms; instead we found that the avolition
dimension of negative symptoms was the main predictor after the
caregivers’ scores, with more severe avolition associated with a
better concordance or even with an underestimation of the SLOF
Interpersonal domain functioning in patient’s self-ratings. We
hypothesize that these results may depend on the different
instruments utilized to assess depression and negative symptoms:
while we utilized an objective (based on clinicians’ observations
during the interview) schizophrenia specific depression rating
scale, the Calgary Depression Scale for Schizophrenia35 (CDSS),
previous studies employed a self-reported scale, namely the Beck
Depression Inventory version I or II5,7,32,36,37. Moreover, the BDI-II
includes items concerning anhedonia, asociality and avolition,
which overlap with the experiential domain of negative symptoms
that we evaluated with the Brief Negative Symptoms Scale
(BNSS)38. Similarly, according to the current conceptualization of
negative symptoms39, we assessed negative symptoms with a
specific second-generation assessment scales, the BNSS, consider-
ing two factors: avolition and expressive deficits40,41, whereas
previous studies did not employ specific scales and considered
negative symptoms as a single variable7,32,37,42–44. These differ-
ences in clinical assessment could at least in part account for our
contrasting results compared with previous works. We suppose
that the avolition dimension of the BNSS, as experiential domain
of negative symptoms including avolition, anhedonia, and
asociality, similarly to depression in other studies45,46, can support
a self-evaluation of real-life functioning similar to the one
provided by the caregiver. In other words, a higher degree of
avolition could enhance a more “objective” perception of patients’
limits of functioning.
The other significant predictors of discrepancies in the SLOF
dimensions evaluation were illness-or cognitive-related factors
that generally had weak associations with the outcome (cf. Table
3). As we found high concordance in all domains, a weak impact of
predictors on disagreement might be expected, because there is
little variance of disagreement to be explained, especially after
adjusting for the caregivers’ score. Moreover, the large size of the
study population might have enhanced statistical significance
even for relatively small effects, which may also be influenced by
the presence of few subjects with extreme values of discrepancy.
For all these reasons, the substantive significance of these
associations seems quite poor and should not be emphasized.
Thus, the absent or weak association of cognitive performance
with disagreement on functioning assessment was an unexpected
result that disconfirmed our research hypothesis.
The patients included in the present study were outpatients
with stable symptoms, moderate degree of functional impairment,
and a strong and stable relationship with mental services and their
Table 4. Multivariable regressions of patient-caregiver discrepancies in SLOF domains.
Patient-caregiver discrepancies in SLOF domains
Interpersonal relationships (n= 613) Everyday life skills (n= 608) Work skills (n= 612)
Caregiver score −0.295 (−0.351; −0.239) <0.001 −0.244 (−0.288; −0.200) <0.001 −0.182 (−0.219; −0.144) <0.001*
PANSS positive −0.116 (−0.190; −0.042) 0.002
PANSS disorganization −0.798 (−1.171; −0.425) <0.001*
BNSS avolition −0.264 (−0.373; −0.156) <0.001 −0.185 (−0.276; −0.094) <0.001
BNSS expressive deficits −0.529 (−0.809; −0.249) <0.001*
Processing speed 0.019 (0.006; 0.031) 0.005
Constant 1.042 (0.746; 1.339) <0.001 1.602 (1.223; 1.981) <0.001 1.233 (0.965; 1.502) <0.001
Note: multivariable regressions performed using multiple imputations and multivariable fractional polynomials (MFP). Linear regression coefficients are
displayed with 95% confidence intervals in brackets and p values. * denotes cubic regression coefficients.
P. Rocca et al.
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caregiver. These characteristics could have helped in achieving a
high level of agreement among patients’ and caregivers’
evaluation. Therefore, the main limitation of the present study is
that our results may not be reproducible in patients in acute
phases, clinically unstable, or assessed in other clinical settings or
in social context were a key caregiver is absent. In addition, the
high degree of agreement made it difficult to identify predictors
of patient-caregiver discrepancy, beside the functioning level
itself.
Despite this limitation, this study has some important strengths:
the large sample size, the naturalistic design without selection bias
related to randomized controlled designs, the use of state-of-the-
art statistical analysis and instruments to assess psychopathology,
cognition, functional capacity, and real-world functioning.
In our sample, people with schizophrenia showed a good
agreement with the caregivers’ ratings of the SLOF scale. It can be
assumed that this good level of concordance is partly owing to
sample characteristics: clinically stable, non-hospitalized patients,
with moderate degree of functional impairment, who often share
background and life context with their caregivers. Moreover, a
good service engagement with continuative community-based
psychiatric care might enhance patients’ metacognitive reflection,
insight, and ability to self-appraise their real-life functioning. In this
view, in contexts in which community-based mental health care is
provided, and in outpatients with clinically stable schizophrenia
and a good engagement with mental health services, self-
evaluation with the SLOF scale can become a useful, informative




We used the 4-year follow-up database of the NIRP study, involving at the
baseline 921 community-dwelling, clinically stable patients47,48. Twenty-
four out of the 26 Italian university psychiatric clinics and/or mental health
departments that joined the baseline study participated in the follow-up.
All patients recruited by the 24 participating centers for the baseline study
were invited to participate.
Patients with a diagnosis of schizophrenia according to the DSM-IV and
confirmed with the Structured Clinical Interview for DSM-IV-Patient version
(SCID-I-P) were included in the follow-up study. Exclusion criteria were (a) a
history of head trauma with loss of consciousness in the 4-year interval
between the baseline and the follow-up assessments; (b) progressive
cognitive deterioration possibly owing to dementia or other neurological
illness diagnosed in the last 4 years; (c) a history of alcohol and/or
substance abuse in the last six months; (d) current pregnancy or lactation;
Fig. 1 Bland–Altman plots of patient-caregiver agreement on SLOF domains. Note: in these Bland–Altman plots circles represent patients;
the upper and lower blue lines represent the 95% limits of agreement; the red line represents the average discrepancy between patients and
caregivers. Cases lying between the blue lines are those whose patient and caregiver scores were with 95% probability concordant; those
lying over the upper blue line are those whose self-reported functioning score was significantly higher than the corresponding score
attributed by the caregiver; cases lying below the upper blue line are those whose self-reported functioning score was significantly lower than
the corresponding score attributed by the caregiver. In the x axes, the mean of patient and caregiver scores is assumed as the more likely
value of patient’s functioning.
P. Rocca et al.
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(e) inability to provide informed consent, and (f) treatment modifications
and/or hospitalization owing to symptom exacerbation in the last three
months.
For the participants in the baseline study who could not be traced or
were deceased, investigators had to fill in a specific form reporting clinical
information available at the last contact and, if available, the cause of
death in case of decease. After receiving a comprehensive explanation of
the study procedures and goals, a written informed consent to participate
in the follow-up procedures was asked to all patients. The authors assert
that all procedures contributing to this work comply with the ethical
standards of the relevant national and institutional committees on human
experimentation and with the Helsinki Declaration of 1975, as revised in
2008. All procedures involving human patients were approved by local
Ethics Committees of the participating centers, and recruitment was
carried out from March 2016 to December 2017.
Procedures
The assessments of the enrolled patients were completed following the
same schedule used in the baseline study47: (1) socio-demographic
information, psychopathological, and neurological assessments on the first
day; (2) neurocognitive, social cognition, and functional capacity assess-
ments on the second day; (3) according to the patient’s preference,
assessment of personal resources and perceived stigma were carried out
on the third day morning, or in the afternoon of any of the days. For real-
life functioning assessment, the patient’s key caregiver, was invited to join
one of the scheduled sessions.
Evaluation of illness-related factors
A clinical form was filled in with information on disease course and
treatments in the previous 4 years, using all available sources of
information (patients, relatives, medical records, and mental health
workers).
The Positive and Negative Syndrome Scale (PANSS)49 was used to rate
symptom severity. Positive symptoms were assessed using four items of
the PANSS: P1(delusions), P3 (hallucinatory behavior), P5 (grandiosity), G9
(unusual thought content). Disorganization was assessed using three items
of the PANSS scale: P2 (conceptual disorganization), N5 (difficulty in
abstract thinking), and G11 (poor attention). We used the consensus 5-
factor solution proposed by Wallwork et al.50; for both dimensions, higher
scores represent greater symptom severity. Negative symptoms were
Fig. 2 Scatterplots of patient-caregiver differences in the three SLOF domains and their significant predictors, with the estimated
regression curve. Note: in these plots, circles represent patients, whose coordinates are given by patient-caregiver difference (Y axis) and
values of its significant predictors according to multivariable fractional polynomial regression (X axis). The blue line represents the estimated
regression curve, with 95% confidence interval as shaded area.
P. Rocca et al.
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assessed using the Italian version of the Brief Negative Symptom Scale
(BNSS)38; the scores of the two domains Avolition (sum of anhedonia,
asociality, and avolition) and expressive deficit (sum of blunted affect and
alogia) were used in statistical analyses (higher scores correspond to
greater severity)40,41. Depressive symptoms were evaluated by the CDSS35;
the total score was used in data analyses (higher scores correspond to
greater severity of depression).
The Measurement and Treatment Research to Improve Cognition in
Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB)51 was used
to assess the following neurocognitive domains: processing speed,
attention/vigilance, working memory, verbal learning, visual learning,
and reasoning and problem solving (for all domains, higher scores
represent better cognitive functioning). The assessment of social cognition
was partly included in the MCCB (Mayer–Salovey–Caruso Emotional
Intelligence Test, MSCEIT, managing emotion section)52, which examines
the regulation of emotions in oneself and in one’s relationships with others
by presenting vignettes of various situations, along with ways to cope with
the emotions depicted in these vignettes. This test was integrated by the
Facial Emotion Identification Test53, measuring emotion recognition, and
The Awareness of Social Inference Test (TASIT)54, which is a theory of mind
(ToM) test consisting of seven scales (positive emotions, negative
emotions, sincere, simple sarcasm, paradoxical sarcasm, sarcasm enriched,
lie), organized into three sections: emotion recognition; social inference
(minimal); social inference (enriched).
Assessment of personal resources
The Resilience Scale for Adults55, a self-administered scale, was used to
assess perception of self, perception of the future, social competence and
family cohesion (higher scores correspond to higher resilience). The Service
Engagement Scale56 was employed to measure patients’ levels of difficulty
to engage with mental health services (higher total score represents
greater difficulty).
Evaluation of context-related factors
The Internalized Stigma of Mental Illness57 questionnaire evaluated the
experience of internalized stigma (higher total score corresponds to
greater experience of internalized stigma). The number of incentives was
registered as a count variable, ranging from 0 to 4, and includes the
availability of a disability pension, access to family practical and financial
support, and registration in the unemployment list.
Assessment of functional capacity and real-life functioning
The short version of the University of California San Diego (UCSD)
Performance-based Skills Assessment Brief (UPSA-B)58 was used to assess
functional capacity. It assesses “financial skills” and “communication skills”.
Participants receive scaled scores for each of the subscales (range= 0–50),
which are summed to create an overall score ranging from 0 to 100. Higher
scores indicate better functional capacity.
Real-life functioning was evaluated using the Specific Level of
Functioning Scale (SLOF, Italian version)59–61 a hybrid instrument that
explores many aspects of functioning. It consists of a 43-item self- or
informant-rated scale of a person’s behavior and functioning, which
assesses the following domains: physical efficiency, skills in self-care,
interpersonal relationships, social acceptability, everyday life skills (e.g.,
shopping, using public transportation), and working skills. Each of the 43
items are rated on a five-point Likert scale, indicating the level of
assistance the participant needs to perform the task, with higher score
indicating better functioning. The SLOF scale differs from the other
outcome measures in emphasizing patient’s current functioning and
observable behavior, as opposed to inferred mental or emotional states,
and focuses on a person’s skills, assets, and abilities rather than deficits.
Moreover, the SLOF does not include items relevant to psychiatric
symptomatology or cognitive dysfunctions. SLOF interpersonal relation-
ships, everyday life skills, and work skills domains were included in
statistical analyses. In this follow-up study, the patients her/himself and
her/his key caregiver separately answered to the 43 SLOF items. The
patient’s key caregiver, preferably the same interviewed in the baseline
study, was chosen as informer as usually, this is the individual most
frequently and closely in contact with the patient in the Italian context.
Training of researchers and inter-rater reliability
Researchers were trained by the coordinating center two months before
the beginning of the follow-up recruitment to ensure consistency with the
baseline data collection procedures. The inter-rater reliability was
evaluated by Cohen’s kappa for categorical variables, and intraclass
correlation coefficient (ICC) for continuous variables. For items showing a
small degree of variation among patients, the percentage of perfect
agreement was calculated. An excellent inter-rater agreement was found
for the SCID-I-P (Cohen’s kappa= 0.91). Good to excellent agreement was
observed for BNSS (ICC= 0.74–0.97), PANSS (ICC= 0.60–0.98, percentage
agreement= 64–100%), CDSS (ICC= 0.76–0.98), and MCCB (ICC= 0.98).
Further details can be found in Galderisi et al.31.
Statistical analysis
The characteristics of the study population were summarized by reporting
continuous variables as mean ± standard deviation and categorical
variables as percentages. Patient-caregiver agreement was first calculated
on each of the 24 items belonging to the interpersonal, activities, and work
domains of the SLOF scale, and subsequently on these three domains. As
the SLOF items are ordinal variables on the 1–5 range, agreement on the
items’ level was assessed by reporting the patients’ and caregivers’ mean
score and their difference, the two-sided Wilcoxon matched-pair test of the
null hypothesis of equality of means, the percentage agreement, the
Gwet’s agreement coefficient (AC) and its related probabilistic benchmark
interval. Gwet’s AC coefficient is recently preferred to Cohen’s kappa family
of coefficients because it has been demonstrated to be more robust,
especially in the presence of skewed data, and to be able to avoid the
paradox of negative agreement62–65. Moreover, Gwet’s ACs are categorized
into the scheme provided by Landis and Koch66 as slight (0.00–0.20), fair
(0.21–0.40), moderate (0.41–0.60), substantial (0.61–0.80), and almost
perfect (0.81–1.00) using a probabilistic assignment, that takes into
account the variance of the estimate38. We applied ordinal weighting to
Gwet’s AC calculation in order to assign an increasing penalty when
disagreement between raters was larger. The three domains of the SLOF
are discrete-continuous variables, therefore for these variables the patient-
caregiver agreement was assessed by reporting the patients’ and
caregivers’ mean score and their difference, the two-sided matched-pair
t test of the null hypothesis of equality of means, the Lin’s concordance
correlation and Somers’s D, which assigns the probability that patients are
less or more likely to overestimate their caregiver’s evaluation on the same
domain. The Bland–Altman plots and LOA for each domain were also
obtained, to understand whether disagreement between patient and
caregiver occurred at particular values along the domains’ score range.
Finally, to investigate which characteristics could predict disagreement,
we performed multivariable linear regressions of the patient-caregiver
score difference for each SLOF domain on a set of covariates including
gender, age, education, positive symptoms, disorganization, avolition,
expressive deficit, depression, the six MCCB items of neurocognition, the
five items of social cognition and functional capacity, adjusted for the
caregiver’s score. These regression models were carried out using MFP on
10 imputed data sets obtained through multiple imputation of predictors’
missing data using chained equations. MFP procedure verified which
functional form (linear or nonlinear, i.e., quadratic, cubic, square root, etc.)
of each variable best represented its relationship with the outcome, and
simultaneously selected those significantly associated to the outcome.
Stata 15.1 was used for all analyses, specifically the user-written procedures
kappaetc63, concord67, scsomersd68, and mfpmi69 allowed to estimate
Gwet’s AC, Lin’s concordance correlation, Somers’ D and MFPs,
respectively.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
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